Jonathan J Greenawalt, LSW | |
2115 W Park Dr, Lorain, OH 44053 | |
(440) 989-4987 | |
(440) 282-4779 |
Full Name | Jonathan J Greenawalt |
---|---|
Gender | Male |
Speciality | Counselor - Addiction (substance Use Disorder) |
Location | 2115 W Park Dr, Lorain, Ohio |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184085839 | NPI | - | NPPES |
CDCA.140854 | Other | OH | LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | (* (Not Available)) | Secondary |
101YA0400X | Counselor - Addiction (substance Use Disorder) | CDCA140854 (Ohio) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jonathan J Greenawalt, LSW 2115 W Park Dr, Lorain, OH 44053-1138 Ph: (440) 989-4987 | Jonathan J Greenawalt, LSW 2115 W Park Dr, Lorain, OH 44053 Ph: (440) 989-4987 |
News Archive
One-fifth of American women ages 50 to 74 have fallen behind on mammography screenings for breast cancer, the Centers for Disease Control and Prevention are reporting. Although the percentage of women in this age group who get a regular breast cancer screening every two years increased steadily during the 1990s, the rate has remained just over 80 percent since 2000, according to the centers' Morbidity and Mortality Weekly Report.
Merrion Pharmaceuticals plc, a pharmaceutical development company, today announces that it has been granted a further U.S. Patent, increasing the protection for their lead product, Orazolâ„¢.
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) suggests that Sweden-the country already thought to have the second highest prevalence of type 1 diabetes in the world-could have 2-3 times more adolescents and young adults with type 1 diabetes than previously estimated.
Medicaid reimbursements for office visits to the doctor and for cancer screening tests vary substantially from state to state. New research in the journal Cancer finds that Medicaid recipients are more likely to receive cancer screening tests when their doctors receive higher reimbursements for routine office visits. In contrast, increased reimbursement rates for screening tests do not have a uniform effect on whether Medicaid beneficiaries get screened.
› Verified 1 days ago